With the share price as a guide, I was anticipating some negative news about fee indexation in Australia or the reintroduction of a fee freeze in the US.
There also at least a portion of the share price decline attributable to the rise in interest rate expectations this year. US 10 year going ~3.8% to ~4.5% this year. Their business model is buying pathology businesses with debt.
Regardless, I did buy a few more today.
Ann: Half Yearly Report and Accounts, page-64
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.68 |
Change
-0.170(0.61%) |
Mkt cap ! $13.31B | |||
| Open | High | Low | Value | Volume |
| $27.99 | $28.00 | $27.57 | $46.39M | 1.675M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $27.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.69 | 6349 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| SHL (ASX) Chart |